Cancer News and Research

Latest Cancer News and Research

Youth immunization rates encouraging: CDC report

According to a survey by the Centers for Disease Control and Prevention (CDC) out Monday, more and more American adolescents are receiving recommended vaccines.

6 Sep 2011

Mental health problems ail nearly half of all Americans: Report

According to a new government report about half of Americans will experience some form of mental health problem at some point in their life. The report stresses that more must be done to help the population with mental health problems.

6 Sep 2011

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

BioDelivery Sciences International, Inc. announced positive preliminary results from its Phase 1 study assessing the pharmacokinetics of a BEMA Buprenorphine/Naloxone formulation.

6 Sep 2011

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

NOXXON Pharma today announced the initiation of a Phase I clinical trial for NOX-H94, the Company's third compound to enter the clinic. NOX-H94 is a Spiegelmer designed to treat anemia of chronic disease by targeting the peptide hormone hepcidin, the key regulator of iron metabolism.

6 Sep 2011

Biologists identify mechanism of H. pylori that damages DNA of gastric mucosal cells

The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world.

6 Sep 2011

AMA releases new Current Procedural Terminology codes

Friday September 2, 2011 the AMA released new Current Procedural Terminology (CPT) codes that will be reported by hospitals, physicians and ambulatory centers providing coverage for additional treatment options for cancer patients.

6 Sep 2011

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.

6 Sep 2011

Biologists reveal why men's ring fingers are longer than their index fingers

Biologists at the University of Florida have found a reason why men's ring fingers are generally longer than their index fingers - and why the reverse usually holds true for women.

6 Sep 2011

Researchers reveal mechanism behind how cells communicate

Cell communication is essential for the development of any organism. Scientists know that cells have the power to "talk" to one another, sending signals through their membranes in order to "discuss" what kind of cell they will ultimately become - whether a neuron or a hair, bone, or muscle. And because cells continuously multiply, it's easy to imagine a cacophony of communication.

6 Sep 2011

Study: No big shift toward higher fatal heart attack rates after menopause in women

Contradicting the long-held medical belief that the risk of cardiovascular death for women spikes sharply after menopause, new research from Johns Hopkins suggests instead that heart disease mortality rates in women progress at a constant rate as they age.

6 Sep 2011

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

QIAGEN today announced that it has entered into a partnership with Eli Lilly and Company for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly. Financial terms of the agreement were not disclosed.

From QIAGEN Manchester Limited 6 Sep 2011

Moderate to severe cognitive impairment has impact on life expectancy

Cognitive impairment, even when detected at an early, mild stage, is a significant predictor of decreased life expectancy.

6 Sep 2011

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announces oral communication of the Phase II clinical trial results of its orphan product Livatag at the annual congress of ILCA, the only international organization devoted exclusively to liver cancer research with participation of worldwide best specialists.

6 Sep 2011

DiaGenic allots options to employees

According to the resolution by the Annual General Meeting on 23 May 2011, the Board of Directors in DiaGenic ASA today allotted options to DiaGenic employees. The share options have strike price of NOK 6.00 per share, which is set based on last week weighted share price + 10%. The options have life of 4 years and can be exercised after 3 years.

5 Sep 2011

Cancer cells with specific genetic defect extra susceptible to therapy that damages DNA

Using a strategy based on treating cancer cells that carry a specific genetic signature - hyper-expression of the protein Myc - with therapy that affects the stability of the cell's DNA, more effective results can be achieved.

5 Sep 2011

Asbestos related cancer risk rises after home renovations: Study

A third wave of asbestos-related cancers is emerging as the rate of malignant mesothelioma caused by exposure to asbestos during home renovations increases dramatically, according to new research.

5 Sep 2011

Circumcision rates decline in the US: Study

A new study has shown that circumcision rates among US baby boys have fallen. According to the Centers for Disease Control and Prevention (CDC), which published the study in the Morbidity and Mortality Weekly Report, circumcision rates dropped from around 62 percent in 1999 to 57 percent in 2008.

5 Sep 2011

Scientists purify PARP protein that shows promise against breast, ovarian cancers

CANCER RESEARCH UK scientists have succeeded in purifying a protein found in bacteria that could reveal new drug targets for inherited breast and ovarian cancers - and other cancers linked to DNA repair faults.

5 Sep 2011

Teenagers use medicines frequently without receiving targeted information about risks and benefits

A large proportion of teenagers regularly and frequently take some form of medication without receiving targeted information about the risks and benefits, according to a review of current research, to be presented at the annual congress of the International Pharmaceutical Federation.

5 Sep 2011

C. sporogenes bacterium could be used as vehicle to deliver drugs in frontline cancer therapy

A bacterial strain that specifically targets tumours could soon be used as a vehicle to deliver drugs in frontline cancer therapy. The strain is expected to be tested in cancer patients in 2013 says a scientist at the Society for General Microbiology's Autumn Conference at the University of York.

5 Sep 2011

Cancer News and Research

Latest Cancer News and Research

Youth immunization rates encouraging: CDC report

Mental health problems ail nearly half of all Americans: Report

Positive results from BDSI's BEMA Buprenorphine/Naloxone formulation Phase 1 study on opioid dependence

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

Biologists identify mechanism of H. pylori that damages DNA of gastric mucosal cells

AMA releases new Current Procedural Terminology codes

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

Biologists reveal why men's ring fingers are longer than their index fingers

Researchers reveal mechanism behind how cells communicate

Study: No big shift toward higher fatal heart attack rates after menopause in women

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Moderate to severe cognitive impairment has impact on life expectancy

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

DiaGenic allots options to employees

Cancer cells with specific genetic defect extra susceptible to therapy that damages DNA

Asbestos related cancer risk rises after home renovations: Study

Circumcision rates decline in the US: Study

Scientists purify PARP protein that shows promise against breast, ovarian cancers

Teenagers use medicines frequently without receiving targeted information about risks and benefits

C. sporogenes bacterium could be used as vehicle to deliver drugs in frontline cancer therapy

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in